Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors

A series of novel N9-heterobivalent β-carbolines has been synthesized. All the novel compounds were tested for their anticancer activity against six tumour cell lines in vitro. Among these molecules, compounds 5b, and 5w exhibited strong cytotoxic activities with IC50 value of lower than 20 μM. Acut...

Full description

Bibliographic Details
Main Authors: Liang Guo, Qin Ma, Wei Chen, Wenxi Fan, Jie Zhang, Bin Dai
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2018.1497619
_version_ 1811233127669956608
author Liang Guo
Qin Ma
Wei Chen
Wenxi Fan
Jie Zhang
Bin Dai
author_facet Liang Guo
Qin Ma
Wei Chen
Wenxi Fan
Jie Zhang
Bin Dai
author_sort Liang Guo
collection DOAJ
description A series of novel N9-heterobivalent β-carbolines has been synthesized. All the novel compounds were tested for their anticancer activity against six tumour cell lines in vitro. Among these molecules, compounds 5b, and 5w exhibited strong cytotoxic activities with IC50 value of lower than 20 μM. Acute toxicities and antitumor efficacies of the selected compounds in mice were also evaluated, compounds 5b and 5w exhibited that tumour inhibition rate of over 40% in the Sarcoma 180 and Lewis lung cancer animal models. Preliminary structure–activity relationships (SARs) analysis indicated that: (1) C1-methylation and C7-methoxylation were favorable for increased activities; (2) 3-Pyridyl or 2-thienyl group substituent into position-1 of the β-carboline core, and the aryl substituent into another β-carboline ring might be detrimental to cytotoxic effects of this class compounds. Investigation of the preliminary mechanism of action demonstrated that compound 5b had obvious angiogenesis inhibitory effects in the chicken chorioallantoic membrane (CAM) assay.
first_indexed 2024-04-12T11:16:17Z
format Article
id doaj.art-f2cdb5f2389a4b1f95de530f08ac22ee
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-04-12T11:16:17Z
publishDate 2019-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-f2cdb5f2389a4b1f95de530f08ac22ee2022-12-22T03:35:30ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742019-01-0134137538710.1080/14756366.2018.14976191497619Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitorsLiang Guo0Qin Ma1Wei Chen2Wenxi Fan3Jie Zhang4Bin Dai5Shihezi UniversityXinJiang Huashidan Pharmaceutical Research Co. Ltd.XinJiang Huashidan Pharmaceutical Research Co. Ltd.XinJiang Huashidan Pharmaceutical Research Co. Ltd.Shihezi UniversityShihezi UniversityA series of novel N9-heterobivalent β-carbolines has been synthesized. All the novel compounds were tested for their anticancer activity against six tumour cell lines in vitro. Among these molecules, compounds 5b, and 5w exhibited strong cytotoxic activities with IC50 value of lower than 20 μM. Acute toxicities and antitumor efficacies of the selected compounds in mice were also evaluated, compounds 5b and 5w exhibited that tumour inhibition rate of over 40% in the Sarcoma 180 and Lewis lung cancer animal models. Preliminary structure–activity relationships (SARs) analysis indicated that: (1) C1-methylation and C7-methoxylation were favorable for increased activities; (2) 3-Pyridyl or 2-thienyl group substituent into position-1 of the β-carboline core, and the aryl substituent into another β-carboline ring might be detrimental to cytotoxic effects of this class compounds. Investigation of the preliminary mechanism of action demonstrated that compound 5b had obvious angiogenesis inhibitory effects in the chicken chorioallantoic membrane (CAM) assay.http://dx.doi.org/10.1080/14756366.2018.1497619heterobivalent β-carbolinecytotoxic activitiesangiogenesis inhibitorsstructure–activity relationship
spellingShingle Liang Guo
Qin Ma
Wei Chen
Wenxi Fan
Jie Zhang
Bin Dai
Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
Journal of Enzyme Inhibition and Medicinal Chemistry
heterobivalent β-carboline
cytotoxic activities
angiogenesis inhibitors
structure–activity relationship
title Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
title_full Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
title_fullStr Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
title_full_unstemmed Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
title_short Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
title_sort synthesis and biological evaluation of novel n9 heterobivalent β carbolines as angiogenesis inhibitors
topic heterobivalent β-carboline
cytotoxic activities
angiogenesis inhibitors
structure–activity relationship
url http://dx.doi.org/10.1080/14756366.2018.1497619
work_keys_str_mv AT liangguo synthesisandbiologicalevaluationofnoveln9heterobivalentbcarbolinesasangiogenesisinhibitors
AT qinma synthesisandbiologicalevaluationofnoveln9heterobivalentbcarbolinesasangiogenesisinhibitors
AT weichen synthesisandbiologicalevaluationofnoveln9heterobivalentbcarbolinesasangiogenesisinhibitors
AT wenxifan synthesisandbiologicalevaluationofnoveln9heterobivalentbcarbolinesasangiogenesisinhibitors
AT jiezhang synthesisandbiologicalevaluationofnoveln9heterobivalentbcarbolinesasangiogenesisinhibitors
AT bindai synthesisandbiologicalevaluationofnoveln9heterobivalentbcarbolinesasangiogenesisinhibitors